Biosafety Practices for In Vivo Viral-Mediated Gene Therapy in the Health Care Setting.

Jill E BlindE Nicole McLeodAlex BrownHinal PatelSumit Ghosh

Published in: Applied biosafety : journal of the American Biological Safety Association (2020)

As biotechnology continues to advance, so will the challenges of incorporating novel therapies into the clinical setting. Health systems must educate themselves on the current recommendations and maintain competency of this evolving science to ensure the safety of patients, families, and staff in the clinical environment.

Keyphrases

healthcare
gene therapy
end stage renal disease
newly diagnosed
ejection fraction
primary care
public health
sars cov
clinical practice
social media